Potential Docking Affinity of Three Approved Drugs Against SARS-CoV-2 for COVID-19 Treatment

enthalten in: chemRxiv.org | 2021

von Rachakulla, V. | Rachakulla, H.

A Computational and Literature-Based Evaluation for a Combination of Chiral Anti-CoV Drugs to Block and Eliminate SARS-CoV-2 Safely

enthalten in: chemRxiv.org | 2021

von Suhail, M.

Double Lock the COVID 19: Inhibit SARS COV 2 Replication and Suppress Inflammation Cytokine Level by the Golden Compounds

enthalten in: chemRxiv.org | 2021

von He, Z. | Zhang, C. | Du, Z. | +10

Indoor Exposure to Commonly Used Disinfectants During the COVID-19 Pandemic

enthalten in: chemRxiv.org | 2021

von Zheng, G. | Filippelli, G. | Salamova, A.

In Silico Identification of Potential Allosteric Inhibitors of the SARS-CoV-2 Helicase

enthalten in: chemRxiv.org | 2021

von Rowaiye, A. | Onuh, O. | Asala, T. | +7

An Integrative in Silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS-CoV-2 Main Protease

enthalten in: chemRxiv.org | 2021

von Djokovic, N. | Ruzic, D. | Djikic, T. | +8

Artificial Intelligence Guided De Novo Molecular Design Targeting COVID-19

enthalten in: chemRxiv.org | 2021

von Srinivasan, S. | Batra, R. | Chan, H. | +3

A Network Medicine Approach to Investigation and Population-based Validation of Disease Manifestations and Drug Repurposing for COVID-19

enthalten in: chemRxiv.org | 2021

von Zhou, Y. | Hou, Y. | Shen, J. | +15

Computational Studies to Identify Potential Main Protease Inhibitors for SARS-CoV-2

enthalten in: chemRxiv.org | 2021

von Sobhia, M. | Ghosh, K. | Sivangula, S. | +2

In Silico Investigation on the Binding of Organoselenium Compounds with Target Proteins of SARS-CoV-2 Infection Cycle

enthalten in: chemRxiv.org | 2021

von Singh, B. | Kunwar, A.